drugset / Trial / NCT03544567
A Study of Oraxol in Subjects With Cutaneous Angiosarcoma
NaSingle-groupOpen-labelTreatment
Summary
This is a non-blinded, multi-center, open-label, phase 2 study to evaluate the activity, safety, and tolerability of Oraxol in subjects with cutaneous angiosarcoma.
Timeline
- Start
- 2018-12-21
- Primary completion
- 2023-05-12
- Completion
- 2023-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HM30181A-US | Unknown | — | Oral |
| Subject | Paclitaxel | Small molecule | — | Oral |